{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:38:01Z","timestamp":1777354681326,"version":"3.51.4"},"reference-count":8,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T00:00:00Z","timestamp":1614384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clin Pharma and Therapeutics"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1002\/cpt.2175","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T19:24:38Z","timestamp":1614453878000},"page":"813-815","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["FDA\u2019s Limited Population Pathway for Antibacterial and Antifungal Drugs"],"prefix":"10.1111","volume":"109","author":[{"given":"Sumathi","family":"Nambiar","sequence":"first","affiliation":[{"name":"Office of New Drugs Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Walinsky","sequence":"additional","affiliation":[{"name":"Office of New Drugs Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Schumann","sequence":"additional","affiliation":[{"name":"Office of New Drugs Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,2,27]]},"reference":[{"key":"e_1_2_9_1_1","unstructured":"United States Food and Drug Administration.Antibacterial Therapies for Patients with an Unmet Medical Need for the Treatment of Serious Bacterial Diseases. <https:\/\/www.fda.gov\/regulatory\u2010information\/search\u2010fda\u2010guidance\u2010documents\/antibacterial\u2010therapies\u2010patients\u2010unmet\u2010medical\u2010need\u2010treatment\u2010serious\u2010bacterial\u2010diseases> (2017). Accessed November 18 2020."},{"key":"e_1_2_9_2_1","unstructured":"CFR Part 312 Subpart E Drugs Intended to Treat Life\u2010threatening and Severely\u2010debilitating Illnesses. <https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?CFRPart=312&showFR=1&subpartNode=21:5.0.1.1.3.5>. Accessed January 6 2021."},{"key":"e_1_2_9_3_1","unstructured":"United States Food and Drug Administration.Guidance for Industry: Limited Population Pathway for Antibacterial and Antifungal Drugs. <https:\/\/www.fda.gov\/media\/113729\/download> (2020). Accessed November 18 2020."},{"key":"e_1_2_9_4_1","unstructured":"United States Food and Drug Administration.Limited Population Pathway for Antibacterial and Antifungal Drugs; Public Meeting; Request for Comments. 84 Fed Reg 12621. <https:\/\/www.federalregister.gov\/documents\/2019\/04\/02\/2019\u201006390\/limited\u2010population\u2010pathway\u2010for\u2010antibacterial\u2010and\u2010antifungal\u2010drugs\u2010public\u2010meeting\u2010request\u2010for> (2019). Accessed November 21 2020."},{"key":"e_1_2_9_5_1","unstructured":"United States Food and Drug Administration.Arikayce new drug application review. <https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2018\/207356Orig1s000TOC.cfm>. Accessed November 23 2020."},{"key":"e_1_2_9_6_1","unstructured":"CFR Part 314 Subpart H Accelerated Approval of New Drugs for Serious or Life\u2010Threatening Illnesses. <https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?CFRPart=314&showFR=1&subpartNode=21:5.0.1.1.4.8>. Accessed November 21 2020."},{"key":"e_1_2_9_7_1","unstructured":"United States Food and Drug Administration.Pretomanid new drug application review. <https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2019\/212862Orig1s000TOC.cfm> Accessed November 23 2020."},{"key":"e_1_2_9_8_1","unstructured":"Plazomicin Antimicrobial Drugs Advisory Committee meeting. <https:\/\/www.fda.gov\/advisory\u2010committees\/advisory\u2010committee\u2010calendar\/may\u20102\u20102018\u2010antimicrobial\u2010drugs\u2010advisory\u2010committee\u2010meeting\u2010announcement>. Accessed November 23 2020."}],"container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.2175","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cpt.2175","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.2175","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T13:38:25Z","timestamp":1699364305000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/cpt.2175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,27]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1002\/cpt.2175"],"URL":"https:\/\/doi.org\/10.1002\/cpt.2175","archive":["Portico"],"relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,27]]},"assertion":[{"value":"2020-12-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}